Niagen Bioscience (NAGE) Amortizatization of Intangibles (2019 - 2024)
Niagen Bioscience (NAGE) posted quarterly Amortizatization of Intangibles of $131000.0 for Q3 2021, up 35.05% year-over-year from $97000.0 in Q3 2020, and up 35.05% quarter-over-quarter from $97000.0 in Q3 2020.
Powered by 
Analysis
Niagen Bioscience (NAGE) Amortizatization of Intangibles (2019 - 2024) Analysis & Trends
Niagen Bioscience (NAGE) has reported Amortizatization of Intangibles for 3 consecutive years, with $131000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Amortizatization of Intangibles rose 35.05% year-over-year to $131000.0; the TTM figure through Sep 2021 stood at $415000.0 (up 10.37% YoY), while the FY2019 annual figure was $515000.0, changed N/A from the prior year.
- Amortizatization of Intangibles advanced to $131000.0 in Q3 2021 per NAGE's latest filing, from $97000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $144000.0 in Q3 2019 and bottomed at $92000.0 in Q4 2019.
- Historically, Amortizatization of Intangibles has averaged $116250.0 across 3 years, with a median of $114000.0 in 2020.
- Annual changes were most pronounced in 2020 — Amortizatization of Intangibles plunged 33.33% — and 2021, when it surged 35.05%.
- Niagen Bioscience's Amortizatization of Intangibles stood at $92000.0 in 2019, then increased by 5.43% to $97000.0 in 2020, then jumped by 35.05% to $131000.0 in 2021.
- Business Quant data shows NAGE's Amortizatization of Intangibles at $131000.0 in Q3 2021, $97000.0 in Q3 2020, and $95000.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 174,000.00 |
| Dec 31, 2023 | 157,000.00 |
| Sep 30, 2023 | 176,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 171,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | 169,000.00 |
| Mar 31, 2022 | 299,000.00 |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 126,000.00 |
| Dec 31, 2020 | 115,000.00 |
| Sep 30, 2020 | 97,000.00 |
| Jun 30, 2020 | 95,000.00 |
| Mar 31, 2020 | 92,000.00 |
| Dec 31, 2019 | 92,000.00 |